Stock TBF1 CANNTAB THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Canntab Therapeutics Limited Deutsche Boerse AG

Equities

TBF1

CA1377991023

Market Closed - Deutsche Boerse AG
Other stock markets
 11:30:59 05/10/2023 am IST 		5-day change 1st Jan Change
0.0005 EUR -.--% Intraday chart for Canntab Therapeutics Limited -.--% -.--%
15/04 Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding CI
2023 Canntab Therapeutics Limited Provide an Update on Product Delivery CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Canntab Therapeutics Limited Announces Chief Executive Office Changes
CI
Canntab Therapeutics Limited Announces the Passing of Jeffrey Ward Renwick, the Co-Founder, Director and President
CI
Canntab Therapeutics Limited Announces Appointment of Larry Latowsky as CEO
CI
Canntab Therapeutics Limited Appoints Joshi Laxminarayan as Chief Scientific Officer
CI
Canntab Therapeutics Limited to Appoint Larry Latowsky as Director and Executive Chairman of the Board
CI
Canntab Therapeutics Limited Announces Resignation of Sheldon Inwentash from its Board of Directors
CI
Canntab Therapeutics Limited Appoints Bob Woloschuk to its Advisory Board
CI
Telferscot Resources, Inc has Changed its Name to Canntab Therapeutics Limited
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PILL Stock
  4. TBF1 Stock
  5. News Canntab Therapeutics Limited
  6. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW